Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://martinazmyb602084.acidblog.net/69996503/trelaglutide-exploring-a-new-treatment-for-chronic-diseases